Connect with us

Hi, what are you looking for?


Tesla stock price forecast: ‘price aggression not supportive of high multiple’

The recent sell-off in shares of Tesla Inc (NASDAQ: TSLA) is not entirely unjustified, says Philippe Houchois. He’s a Senior Analyst at Jefferies.

Jefferies’ updated Tesla stock price forecast

On Wednesday, Houchois downgraded the electric vehicles company to “hold” and slashed his price objective to $185.

The analyst attributes his Tesla stock price forecast to Elon Musk shifting focus from margins to volumes.

However fascinating the investment case remains, relative price aggression is not supportive of a high multiple investment case while unfolding.

Last week, the Nasdaq-listed firm said about half a dozen price cuts this year resulted in an 800-bps year-on-year hit to its automotive gross profit margin in the first quarter as Invezz reported HERE. Tesla shares are still up 45% for the year.

Tesla needs to improve in marketing and planning

Houchois agreed that it made sense for Tesla to focus on volumes since the EV giant wants to be selling 20 million vehicles per year by 2030.

But that transition, the analyst noted, was unlikely to bear good news for Tesla shares. His research note also said:

With multiple technical edges from software to batteries and manufacturing productivity, Tesla clearly overperforms on engineering but has fallen behind in building skills in marketing and product planning.

Several other automakers have already launched their electric vehicles in the market. Rising competition could be another headwind for TSLA moving forward. Nonetheless, Houchois’ Tesla stock price forecast still suggests about a 20% upside from here.

The post Tesla stock price forecast: ‘price aggression not supportive of high multiple’ appeared first on Invezz.

Enter Your Information Below To Receive Free Trading Ideas, Latest News And Articles.

    Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

    You May Also Like

    Latest News

    Rep. Jennifer Wexton (D-Va.) announced on Tuesday that she has been diagnosed with Parkinson’s Disease. “If there’s one thing that Democrats and Republicans can...

    Latest News

    After Dianne Feinstein announced she’d contracted the shingles in early March, her staff said she planned to return to the Senate within a matter...


    A U.S. District Court judge has ruled that Elizabeth Holmes, founder and CEO of the disgraced blood-testing company Theranos, cannot remain free on bail...

    Latest News

    SEOUL, South Korea — When a group of American lawmakers arrived in South Korea for meetings with government and military officials, President Yoon Suk-yeol...

    Disclaimer:, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2022 All Rights Reserved.